Targeting the gastrin-releasing peptide receptor pathway to treat cognitive dysfunctionassociated with Alzheimer’s Disease

Increasing evidence indicates that bombesin (BB)-like peptides (BLPs), such as the gastrin-releasing peptide (GRP) and its receptor (GRPR), might play a role in neurological and psychiatric disorders. The present study reviews findings from animal and human studies suggesting that the GRPR should be...

Descripción completa

Detalles Bibliográficos
Autores principales: Roesler, Rafael, Luft, Tatiana, Schwartsmann, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2007
Materias:
Views & Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619558/
https://www.ncbi.nlm.nih.gov/pubmed/29213377
http://dx.doi.org/10.1590/s1980-57642008dn10200002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619558/
https://www.ncbi.nlm.nih.gov/pubmed/29213377
http://dx.doi.org/10.1590/s1980-57642008dn10200002

Ejemplares similares